Home › NDC Lookup › RxCUI directory › RxCUI 313584

Venlafaxine 37.5 MG Oral Tablet — RxCUI 313584

RxNorm drug concept · Semantic clinical drug
RxCUI 313584 Semantic clinical drug · SCD ● Current RxNorm concept 78 FDA products 220 package NDCs Snapshot Jul 14, 2026

This page is curated, coded, and maintained by

Compiled from public NLM RxNorm and FDA (openFDA NDC directory) data sources. Editorial policy

What you’re looking at: the standardized identity of one medicine, as the U.S. drug-data system sees it. Below — every FDA-listed product, package code, price benchmark, and billing code that maps to it.

🗂️ Key Facts

RxCUI313584
Official nameVenlafaxine 37.5 MG Oral Tablet
Concept typeSemantic clinical drug (SCD)
RxNorm statusCurrent RxNorm concept
Also known asvenlafaxine 37.5 MG (as venlafaxine hydrochloride 42.5 MG) Oral Tablet; venlafaxine HCl 37.5 MG Oral Tablet
FDA products mapped78
Package NDCs mapped220
Reported Medicaid activity (SDUD)213,978 prescriptions · 52 state & territory Medicaid programs · latest period Q4 2025
RxNorm release07/06/2026
Snapshot dataJul 14, 2026

📖 Skip the Codes — Read It in Plain English.

Our pharmacist-built guide to Venlafaxine: what it is, how it’s used, side effects, and interactions.

📗 Our plain-language guide HelloPharmacist
  • Venlafaxine treats major depressive disorder in all its forms. Depending on which formulation you're prescribed, it can also treat generalized anxiety disorder, social anxiety diso...
  • Most people don't feel a full benefit right away — it typically takes several weeks before you notice a meaningful improvement in mood or anxiety. Blood levels stabilize within abo...
  • How long does it take for venlafaxine to start working?
  • The most common side effects are nausea, dry mouth, sweating, drowsiness or insomnia, dizziness, and decreased appetite — and many of these tend to improve after the first couple o...
📖 Read our full Venlafaxine guide →

🕸️ Concept Web — How Venlafaxine 37.5 MG Oral Tablet Connects

One RxCUI never lives alone. Follow the path from the raw ingredient down to the exact strength-and-form concepts FDA products carry — every stop is a real RxNorm concept with its own identifier. Hover or focus any chip for what it means.
This page's concept Venlafaxine 37.5 MG Oral Tablet RxCUI 313584

Every web starts here: one RxCUI, one fixed meaning in the RxNorm vocabulary.

  1. Ingredients 1

    The active substance itself — no strength, form, or brand attached yet.

    • Venlafaxine 39786
  2. Dose forms 6

    The ingredient poured into a form — tablet, solution, cream — still without one fixed strength.

    • Venlafaxine Oral Tablet 374285
    • Venlafaxine Oral Product 1164574
    • Venlafaxine Pill 1164575
    • Oral Tablet 317541
    • Oral Product 1151131
    • Pill 1151133
  3. Clinical & branded drugs 1

    Ingredient + strength + dose form. These are the concepts real FDA products actually carry.

    • Venlafaxine 37.5 MG 328799

Showing up to 8 concepts per family — 8 of 8 stored related concepts drawn.
These are official RxNorm vocabulary relationships — how concepts name and organize the same medicine. They do not establish therapeutic equivalence or substitutability: two concepts appearing in one web is never a statement that products can be swapped.

🔀 Generic ⇄ Brand Crosswalk

The same medicine has an unbranded (generic) identity and one or more brand-name identities — each with its own RxCUI. This is a naming relationship in RxNorm, not a statement that any two products are substitutable.

Generic (Clinical) Concepts

  • Venlafaxine 37.5 MG SCDC · 328799
  • Venlafaxine Oral Tablet SCDF · 374285
  • Venlafaxine Oral Product SCDG · 1164574
  • Venlafaxine Pill SCDG · 1164575

📦 FDA Products & Package NDCs

78 products · 220 package NDCs
220 package NDCs map to RxCUI 313584 in the current snapshot — up to 50 per page. Each linked NDC opens its full package page.
Package NDC Package Brand / generic name Labeler Marketing start
68382-0101-06 30 TABLET in 1 BOTTLE (68382-101-06) Venlafaxine Zydus Pharmaceuticals USA Inc. 2008-06-13
68382-0101-10 1000 TABLET in 1 BOTTLE (68382-101-10) Venlafaxine Zydus Pharmaceuticals USA Inc. 2008-06-13
68382-0101-14 60 TABLET in 1 BOTTLE (68382-101-14) Venlafaxine Zydus Pharmaceuticals USA Inc. 2008-06-13
68382-0101-16 90 TABLET in 1 BOTTLE (68382-101-16) Venlafaxine Zydus Pharmaceuticals USA Inc. 2008-06-13
70518-1385-00 30 TABLET in 1 BLISTER PACK (70518-1385-0) venlafaxine REMEDYREPACK INC. 2018-08-24
70518-1385-01 90 TABLET in 1 BOTTLE, PLASTIC (70518-1385-1) venlafaxine REMEDYREPACK INC. 2018-10-04
70518-1385-03 60 TABLET in 1 BOTTLE, PLASTIC (70518-1385-3) venlafaxine REMEDYREPACK INC. 2023-11-07
71209-0025-05 100 TABLET in 1 BOTTLE (71209-025-05) VENLAFAXINE Cadila Pharmaceuticals Limited 2018-12-03
71209-0026-05 100 TABLET in 1 BOTTLE (71209-026-05) VENLAFAXINE Cadila Pharmaceuticals Limited 2018-12-03
71209-0027-05 100 TABLET in 1 BOTTLE (71209-027-05) VENLAFAXINE Cadila Pharmaceuticals Limited 2018-12-03
71209-0028-05 100 TABLET in 1 BOTTLE (71209-028-05) VENLAFAXINE Cadila Pharmaceuticals Limited 2018-12-03
71209-0029-05 100 TABLET in 1 BOTTLE (71209-029-05) VENLAFAXINE Cadila Pharmaceuticals Limited 2018-12-03
71335-1213-01 30 TABLET in 1 BOTTLE (71335-1213-1) venlafaxine Bryant Ranch Prepack 2022-02-09
71335-1213-02 60 TABLET in 1 BOTTLE (71335-1213-2) venlafaxine Bryant Ranch Prepack 2022-02-09
71335-1213-03 90 TABLET in 1 BOTTLE (71335-1213-3) venlafaxine Bryant Ranch Prepack 2022-02-09
71335-1213-04 10 TABLET in 1 BOTTLE (71335-1213-4) venlafaxine Bryant Ranch Prepack 2022-02-09
71335-9704-01 30 TABLET in 1 BOTTLE (71335-9704-1) Venlafaxine Bryant Ranch Prepack 2023-04-24
71335-9704-02 60 TABLET in 1 BOTTLE (71335-9704-2) Venlafaxine Bryant Ranch Prepack 2023-06-27
71335-9704-03 90 TABLET in 1 BOTTLE (71335-9704-3) Venlafaxine Bryant Ranch Prepack 2023-10-10
71335-9704-04 10 TABLET in 1 BOTTLE (71335-9704-4) Venlafaxine Bryant Ranch Prepack 2024-04-05
Observed labelers: Aurobindo Pharma Limited (32) · Dr. Reddy's Laboratories Limited (30) · Zydus Lifesciences Limited (30) · Zydus Pharmaceuticals USA Inc. (30) · Alembic Pharmaceuticals Inc. (15) · Alembic Pharmaceuticals Limited (15) · +15 more — this is the FDA-listed mapping footprint, not sales, inventory, availability, or market share.

🗃️ Sources & Limits

Atlas generation902fddb9-e9c1-4004-bf4c-dba4d51037c7
openFDA export observedJul 14, 2026
RxNorm release07/06/2026
Methodology2026-07-full-catalog-v1
  • A shared RxCUI does not prove interchangeability. Products mapped to the same concept are not thereby equivalent or substitutable — equivalence is a separate, product-level determination.
  • Listing here does not establish approval or coverage. Appearing in this snapshot is a data observation, not an FDA approval status or a payer coverage decision.
  • Missing data never means zero. A silent dataset (no price, no billing code, no utilization) means no observation — not that the real-world value is zero.
  • Counts describe the mapping footprint. Product, package, and labeler counts are the FDA-listed mapping footprint in this snapshot — not sales, inventory, availability, or market share.
This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product.

Machine-readable JSON

Reference information about drug-concept identifiers and public regulatory data — not medical advice. Talk to your pharmacist or prescriber about your own medication.